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The Deacetylase HDAC6
Regulates Aggresome Formation and Cell Viability
in Response to Misfolded Protein Stress
J.J. Kovacs and T.-P. Yao, submitted). Although it is not
apparent why a deacetylase would associate with a mi-
crotubule-associated motor and ubiquitinated proteins,
these observations suggest an intriguing possibility that
HDAC6 might be involved in connecting dynein motor-
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misfolded protein aggregates. Misfolded proteins re-
sulting from genetic mutations, inappropriate protein
assembly, aberrant modifications, and environmentalSummary
stress are the inevitable byproducts of biogenesis. More
than simply being nonfunctional, misfolded proteins areThe efficient clearance of cytotoxic misfolded protein
prone to forming aggregates that can interfere with nor-aggregates is critical for cell survival. Misfolded pro-
mal cellular function (Plemper and Wolf, 1999). Thus,tein aggregates are transported and removed from
misfolded proteins are closely monitored, processed,the cytoplasm by dynein motors via the microtubule
and degraded to prevent their accumulation in cells. Thenetwork to a novel organelle termed the aggresome
degradation of misfolded proteins, which are recognizedwhere they are processed. However, the means by which
and often polyubiquitinated by a complex network ofdynein motors recognize misfolded protein cargo, and
proteins, is carried out primarily by the proteasomethe cellular factors that regulate aggresome formation,
(reviewed in Kopito, 1997). However, once aggregated,remain unknown. We have discovered that HDAC6, a
misfolded proteins are not degraded efficiently by pro-microtubule-associated deacetylase, is a component
teasome machinery. As aggregated proteins are toxic,of the aggresome. We demonstrate that HDAC6 has
their efficient disposal is essential for cell survivalthe capacity to bind both polyubiquitinated misfolded
(reviewed in Kopito, 2000). In fact, failure to degradeproteins and dynein motors, thereby acting to recruit
misfolded and aggregated proteins is a dominant con-misfolded protein cargo to dynein motors for transport
tributing factor to neuronal cell death in many neurode-to aggresomes. Indeed, cells deficient in HDAC6 fail
generative diseases (Thomas et al., 1995; Lam et al.,to clear misfolded protein aggregates from the cyto-
2000).plasm, cannot form aggresomes properly, and are hy-
The pathway responsible for the clearance of mis-persensitive to the accumulation of misfolded pro-
folded protein aggregates is poorly understood. Theteins. These findings identify HDAC6 as a crucial player
recent discovery of a novel cellular structure, the aggre-in the cellular management of misfolded protein-
some, provides an important clue that may help eluci-induced stress.
date the players in this pathway. Aggresomes were first
identified in the characterization of a mutant form ofIntroduction
the cystic fibrosis transmembrane conducting regulator
CFTR-F508, which is prone to misfolding and aggrega-Histone deacetylases (HDACs) are a family of enzymes
tion. Similar to many misfolded proteins, misfoldedwhose functions have been overwhelmingly associated
CFTR-F508 becomes polyubiquitinated and is de-with gene expression and chromatin dynamics (re-
graded by proteasomes (Jensen et al., 1995; Ward et al.,
viewed in Ayer, 1999). However, recent evidence indi-
1995). Upon inhibition of proteasome activity, however,
cates that not all functions of HDACs are dedicated to
misfolded CFTR-F508 accumulates, forms aggre-
regulating gene transcription and chromatin remodeling gates, and strikingly, becomes concentrated into a sin-
(reviewed in Verdin et al., 2003). The prominent example gle prominent juxtanuclear inclusion body that was
of such a noncanonical function is illustrated by the termed the aggresome (Johnston et al., 1998). Subse-
cytoplasmic deacetylase HDAC6. We and others have quent studies established that aggresomes are induced
previously reported that HDAC6 is a microtubule-asso- by ectopic expression of many different misfolded pro-
ciated deacetylase that can regulate microtubule acety- teins and are major repositories for misfolded protein
lation and chemotactic cell motility (Hubbert et al., 2002; aggregates. It has thus been proposed that aggresome
Matsuyama et al., 2002; Zhang et al., 2003; Haggarty et formation is a specific and active cellular response to
al., 2003). There are, however, two unusual properties cope with excessive levels of misfolded and aggregated
associated with HDAC6 whose significance is not under- proteins (reviewed in Kopito, 2000). Supporting the role
stood. First, HDAC6 shows extensive colocalization with of aggresomes in processing misfolded protein aggre-
p150glued (Hubbert et al., 2002), a component of the dyn- gates, components of proteasomes and molecular
ein motor complex. Second, HDAC6 contains an ubiqui- chaperones are actively recruited to, and are abundantly
tin binding zinc finger, and becomes associated with present in, aggresomes (reviewed in Garcia-Mata et al.,
ubiquitinated proteins upon inhibition of proteasome ac- 2002; Kopito, 2000). Aggresomes are also of clinical
tivity (Hook et al., 2002; Seigneurin-Berny et al., 2001; interest as they are similar to the cytoplasmic inclusion
bodies commonly observed in many neurodegenerative
diseases. Aggresomes and Lewy bodies, the hallmark*Correspondence: yao00001@mc.duke.edu
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cytoplasmic inclusion bodies found in neurons affected tion, misfolded protein stress response, and neurode-
generative disease.by Parkinson’s disease, share remarkable biochemical
and morphological characteristics (McNaught et al.,
2002). Aggresomes might therefore be fundamentally Results
important in both misfolded protein-induced stress re-
sponse and the pathogenesis of neurodegenerative dis- HDAC6 Is a Component of Aggresomes
ease. However, little is known about the regulation of We have previously found that HDAC6 associates with
aggresome formation. ubiquitinated cellular proteins when proteasome activity
Aggresomes are uniquely located in close proximity is inhibited (J.J. Kovacs and T.-P. Yao, submitted). To
to the microtubule-organizing center (MTOC). This local- further examine the significance of this interaction, we
ization reflects the fact that aggresome formation requires determined the subcellular localization of HDAC6 in re-
the microtubule network and the microtubule-associ- sponse to the proteasome inhibitor MG132. As we have
ated motor, dynein (Wojcik et al., 1996; Garcia-Mata reported, in untreated cells, the immunolocalization of
et al., 1999; Johnston et al., 2002). Disruption of the HDAC6 displays a punctate cytoplasmic staining with a
microtubule network, or dynein motor function, was specific concentration in the perinuclear region and at
shown to prevent aggresome formation, and led to the the leading edge (Figure 1Aa). Strikingly, treatment of
appearance of dispersed foci of misfolded protein ag- cells with the proteasome inhibitor MG132 causes a
gregates throughout cytoplasm (Johnston et al., 1998; dramatic relocation of HDAC6 to a single prominent
Garcia-Mata et al., 1999). These observations led to a juxtanuclear structure that is easily discernable as a
model whereby the dynein motor complex, a minus end- dark inclusion body under phase contrast microscopy
directed motor that moves toward the MTOC, acts to (Figures 1Ae and 1Ah). The morphology and localization
collect and transport misfolded and aggregated proteins of this MG132-induced, HDAC6-enriched inclusion body
from the cytoplasm to the aggresome for degradation. appear to resemble that of an aggresome. Indeed, pro-
However, the mechanism whereby polyubiquitinated teasome inhibitors are known to induce aggresome
misfolded protein aggregates are recognized by, and formation by preventing the degradation of misfolded
loaded onto, dynein motors for transport to aggresomes proteins (Johnston et al., 1998). We therefore further
is not known. characterized the observed HDAC6-enriched inclusion
Most aggresomes, including those induced by CFTR- body for its localization to the microtubule organization
F508, are enriched in polyubiquitin. However, some center (MTOC) and the presence of known components
aggresomes, such as those formed by the expression of aggresomes: the intermediate filament vimentin, pro-
of misfolded GFP-250 (Garcia-Mata et al., 1999) and a teasomes, and polyubiquitin. As shown by immunostain-
mutant superoxide dismutase (SOD) (Johnston et al., ing in Figure 1A, the HDAC6-containing inclusion body
2000), do not contain appreciable polyubiquitin. The dif- is localized at the microtubule organizing center (MTOC),
ferential polyubiquitin content in aggresomes is corre- as revealed by the presence of -tubulin (Figure 1Aj), is
lated with the fact that misfolded CFTR-F508 is polyu- surrounded by vimentin (Figure 1Af), and is enriched
biquitinated, but GFP-250 and SOD are not (Jensen et with both 20S proteasome subunits and polyubiquitin
al., 1995; Garcia-Mata et al., 1999; Johnston et al., 2000). (Figures 1Am and 1Ap). Thus, the HDAC6-positive inclu-
These observations indicate that not all misfolded pro- sion bodies exhibit the characteristics of an aggresome.
tein aggregates processed by aggresomes are polyubi- Aggresome formation is proposed to be a cellular
quitinated. However, it is not known how the dynein response to increasing levels of misfolded proteins in
motor is able to recognize both the polyubiquitinated cells (Johnston et al., 1998). To further investigate
and nonubiquitinated misfolded proteins, or whether it whether HDAC6 is involved in the misfolded protein-
recruits these two different protein cargos via the same induced stress response, we treated cells with tuni-
or different mechanism. camycin, DTT, and thapsigargin, all potent agents that
In this report, we provide evidence of a functional induce protein misfolding. All of these ER-stress-induc-
interaction between HDAC6, dynein motors, and polyu- ing agents cause aggresome formation and a prominent
biquitinated misfolded proteins that is essential for ag- relocalization of HDAC6 to this structure (Figures 1Bc–
gresome formation. We show that HDAC6 is selectively 1Bf and data not shown). Together, these results dem-
involved in polyubiquitin-enriched aggresome formation onstrate that HDAC6 translocates to aggresomes in re-
in cultured cells, and also highly concentrated in Lewy sponse to agents that increase levels of misfolded
bodies in brain tissues affected by Parkinson’s disease. proteins.
Mechanistically, we show that HDAC6 has the capacity
to bind both the model polyubiquitinated misfolded pro- HDAC6 Selectively Localizes to Ubiquitin-
tein CFTR-F508 and the dynein motor. We propose Positive Aggresomes
that HDAC6 facilitates the loading of polyubiquitinated Aggresomes can be classified as polyubiquitin-positive
misfolded cargo to dynein motors for transport to the and polyubiquitin-negative. To investigate whether
aggresome. Indeed, loss of HDAC6 impairs the recruit- HDAC6 is involved in a specific type of aggresome, we
ment of polyubiquitinated proteins to dynein, the clear- examined the localization of HDAC6 in relation to CFTR-
ance of misfolded protein aggregates from the cyto- F508-induced polyubiquitin-enriched aggresomes and
plasm, and aggresome formation. These deficiencies GFP-250-induced polyubiquitin-deficient aggresomes.
cause a hypersensitivity to misfolded protein-induced We used a GFP-CFTR-F508 fusion protein to study
stress resulting in apoptosis. Our findings uncover a CFTR-F508 throughout this report (Johnston et al.,
1998). As shown in Figures 2Aa–2Ac, almost all CFTR-surprising role for a deacetylase in aggresome forma-
HDAC6 Regulates Aggresome Formation
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Figure 1. HDAC6 Is a Component of Aggresomes
(A) A549 cells were treated with DMSO or MG132 (5 M) for 24 hr, and double immunostained with antibodies to HDAC6 (a, e, i, and l; red)
and vimentin (b and f; green), -tubulin (j; green), or 20S-proteasome (m; green) as indicated. For colocalization with ubiquitin-protein conjugates,
A549 cells were transfected with FLAG-tagged HDAC6 expression plasmid and double immunostained with antibodies for FLAG (o; red) and
ubiquitin-protein conjugates (p; green). Superimposed confocal images (merge) demonstrate the colocalization of HDAC6 with various aggre-
some markers (c, g, k, n, and q). Aggresome (arrowheads) formation is also shown by phase contrast microscopy (d and h).
(B) COS7 cells were treated with DMSO or an ER-stress inducing agent, thapsigargin (1 M, 24 hr), and immunostained with an antibody to
HDAC6 (a, c, and e; red), vimentin (b and d; green), or 20S proteasome (f; green). Scale bar  3 m.
F508 becomes concentrated in aggresomes when pro- that are enriched with a polyubiquitinated misfolded
protein.teasome activity is inhibited. In CFTR-F508-positive
aggresomes, an intense signal for HDAC6 is invariably
observed by immunostaining (Figures 2Af–2Ah). In fact, HDAC6 Binds Polyubiquitinated CFTR-F508
We next addressed how HDAC6 is selectively involvedprominent colocalization between HDAC6 and CFTR-
F508 aggregates can be observed in the cytoplasm in the polyubiquitin-positive, but not polyubiquitin-defi-
cient, aggresomes. The presence of an ubiquitin bindingeven prior to their transport to aggresomes (Figures 2Ab,
2Ag, and 2Al, insets). In stark contrast, little HDAC6 is domain (the BUZ finger) suggests the possibility that
the association of HDAC6 with aggresomes might befound in the GFP-250-containing aggresomes, despite
the formation of prominent aggresomes upon GFP-250 mediated by its binding to polyubiquitinated misfolded
proteins. To test this hypothesis, we asked whetherexpression (Figures 2Ae, 2Aj, and 2Ao). The specificity
for HDAC6 translocation to CFTR-F508-aggresomes HDAC6 could bind polyubiquitinated misfolded species
of CFTR-F508. As shown in Figure 2B, after MG132is further supported by the fact that related class II family
members HDAC10 and HDAC4 (Guardiola and Yao, treatment, immunoprecipitation of HDAC6 brought
down a smear of CFTR-F508-containing high molecu-2002; Zhao et al., 2001) are not concentrated in the
CFTR-F508 aggresomes (Figures 2Ad, 2Ai, and 2An, lar weight proteins (lane 2, top panel). These protein
species are apparently ubiquitinated, as they are recog-and data not shown). These observations demonstrate
that HDAC6 is selectively associated with aggresomes nized by an antibody for ubiquitin (lane 2, middle panel).
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Figure 2. HDAC6 Selectively Localizes to Ubiquitin-Positive Aggresomes through Binding via its BUZ Finger
(A) A549 cells were transfected with expression plasmids for GFP-CFTR-F508 or GFP-250 as indicated. GFP-CFTR-F508 transfected cells
were treated with MG132 (5 M) for 6–24 hr, and visualized with an antibody to GFP (a–d, green) or HDAC6 (f–h; red). Insets in (b), (g), and
(l) are high-magnification images of the regions indicated by small arrows that show the colocalization of HDAC6 with small aggregates of
CFTR-F508 (l; yellow). Transfected FLAG-HDAC10 was visualized with an antibody to FLAG (i; red). The colocalization of HDAC6 with GFP-
250 aggresomes was assessed at 24 hr after GFP-250 transfection (e, j, and o). Large arrowheads indicate aggresomes. Scale bar  5 m.
(B) 293T cells were transfected with FLAG-tagged wild-type or BUZ mutant HDAC6, GFP-CFTR-F508, or GFP-250 plasmids, and in the
presence or absence of MG132 (5 M, for 6 hr) as indicated. FLAG-tagged HDAC6 were immunoprecipitated with an antibody to FLAG (M2),
followed by immunoblotting with a GFP antibody (top panel), and then reblotted with an ubiquitin antibody (middle panel). The GFP-CFTR-
F508 coimmunoprecipitated with wild-type HDAC6 was detected as high molecular weight proteins (HMW) (lane 2, top panel), and appears
to be recognized by an antibody to ubiquitin (lane 2, middle panel). Note that other HDAC6-associated ubiquitinated proteins were also
detected (lane 2, middle panel, asterisk). The expressions of transfected plasmids were confirmed by immunoblotting (lanes 1–5, bottom
panel, and lanes 6–7). WCL: whole cell lysate.
Importantly, HDAC6 does not bind the nonubiquitinated presence of HDAC6 in the CFTR-F508 aggresomes
but absence from the GFP-250 aggresomes (Figure 2A).form of CFTR-F508 (lane 6). Further supporting the idea
that HDAC6 selectively binds polyubiquitinated CFTR- Together, these results establish that HDAC6 can specif-
ically bind polyubiquitinated misfolded CFTR-F508F508 through the ubiquitin binding BUZ finger, deletion
of this motif abrogates this interaction (lane 4, top panel). through its C terminus zinc finger, and that this ubiquitin
binding capacity might be the basis for the selectiveWild-type HDAC6 does not interact with GFP-250, which
is not subject to polyubiquitination (lane 5). This binding involvement of HDAC6 in ubiquitin-enriched aggre-
somes.specificity is in complete agreement with the selective
HDAC6 Regulates Aggresome Formation
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Figure 3. MG132 Treatment Stimulates an HDAC6-Dynein-Ubiquitinated Protein Complex Formation
(A) MG132 treatment induces the interaction of HDAC6 with dynein. A549 cells untreated or treated with MG132 (5M, 4 hr) were immunoprecipi-
tated with a dynein antibody (lanes 3 and 4), followed by immunoblotting with an antibody to HDAC6 or dynein as indicated. 10% of total cell
lysates used in immunoprecipitation are shown as input (lanes 1 and 2).
(B) A549 cells treated with DMSO or MG132 (5 M) for 12–24 hr were immunostained with an antibody for HDAC6 (a, d, and g) or dynein (b,
e, and h). Superimposed confocal images (merge, yellow) demonstrate the colocalization of HDAC6 and dynein in aggresomes (large arrow-
heads). Insets in (d)–(f) are high-magnification images of the region indicated by small arrows, and show small foci containing both HDAC6
and dynein (f; yellow). Scale bar  5 m.
(C) Identification of dynein motor binding (DMB) motif. FLAG tagged wild-type and HDAC6 deletion mutants were generated as diagramed
(top panel). 293T cells transfected with wild-type or mutant HDAC6 constructs were treated MG132 (5M, 4 hr). The lysates were immunoprecipi-
tated with an antibody for dynein, followed by immunoblotting with an antibody for FLAG (upper panel), and then reblotted for dynein (middle
panel). 10% of total cell lysates used in immunoprecipitation are shown as input (lower panel).
(D) Cell lysates from control or HDAC6 knockdown cells treated or not treated with MG132 (5 M, 4 hr) were immunoprecipitated with a dynein
antibody followed by immunoblotting with antibodies for ubiquitin, HDAC6, and dynein as indicated. Note that dynein immunoprecipitation
brought down a series of ubiquitinated proteins from MG132-treated control A549 (lane 2, top panel), but not from HDAC6 knockdown cells
(lane 4). Also note an increase in the interaction between HDAC6 and dynein after MG132 treatment (lane 1 and 2, middle panel). Asterisk:
immunoglobulin heavy chain.
(E) HDAC6 knockdown cell lines show a significantly lower level of HDAC6. Whole cell lysates from control and HDAC6 A549 knockdown cells
were immunoblotted for HDAC6 and total tubulin.
HDAC6 Associates with the Dynein Motor a component of the dynein motor complex (Hubbert et
al., 2002). As HDAC6 can bind polyubiquitinated mis-Complex and Recruits Polyubiquitinated
Proteins to Dynein folded CFTR-F508 (Figure 2B), we investigated the
possibility that HDAC6 links the polyubiquitinated mis-The mechanism by which dynein motors recognize mis-
folded proteins, including CFTR-F508, is not known. folded proteins and the dynein motor. To evaluate this
hypothesis, we first determined whether HDAC6 physi-We have previously shown that HDAC6 is associated
with microtubules and partially colocalizes with p150glued, cally interacts with the dynein motor complex. Coimmu-
Cell
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noprecipitation assays demonstrated a constitutive but knockdown cells (compare Figures 4Ac and 4Ad). These
results demonstrate that HDAC6 is required for aggre-weak interaction between endogenous HDAC6 and dyn-
ein (Figure 3A, lane 3) and p150glued (data not shown). some formation induced by ectopic expression of CFTR-
F508, but not GFP-250.This interaction, however, was markedly stimulated
when cells were treated with the proteasome inhibitor To investigate whether HDAC6 is required for aggre-
some formation induced by endogenous misfolded pro-MG132 (compare lanes 3 and 4). This observation is
consistent with the idea that formation of an HDAC6- teins, we examined aggresome formation in control and
HDAC6 knockdown cells in response to MG132 treat-dynein complex is stimulated by increasing levels of
misfolded proteins in response to MG132 treatment. ment alone. As shown in Figures 4B and 4D, a clearly
visible aggresome can be identified in most control A549Supporting this conclusion, immunolocalization studies
demonstrated that dynein (Figures 3Bd–3Bf, insets) and cells (77%) after 24 hr of MG132 treatment. In contrast,
under the same treatment, a majority of the HDAC6p150glued (data not shown) both concentrate in MG132-
induced small cytoplasmic aggregate foci and aggre- knockdown cells (60%) failed to form a visible perinu-
clearly localized inclusion body, i.e., aggresome, butsomes and clearly colocalize with HDAC6. By deletion
mutant analysis, a 65 amino acid polypeptide adjacent instead contained small ubiquitin-positive microaggre-
gates in the cytoplasm (Figure 4Bb). This observationto the second catalytic domain of HDAC6 was found to
be sufficient to mediate dynein motor binding (DMB, indicates that transport of polyubiquitinated protein ag-
gregates from the peripheral cytoplasm to juxtanuclearFigure 3C). Together, these results demonstrate that
HDAC6 associates with the dynein motor complex via aggresomes is compromised in these cells. Importantly,
in HDAC6 knockdown cells that do form visible aggre-a specific domain, and this interaction is enhanced by
MG132 treatment that induces aggresomes. somes in response to MG132 (40% of cells), aggre-
some size is significantly smaller than those observedTo directly test the hypothesis that HDAC6 recruits
polyubiquitinated misfolded proteins to the dynein mo- in control cells (compare Figures 4Ca and 4Cc with 4Cb
and 4Cd; mean volume shown in 4E). These results sup-tor, we first determined whether dynein associates with
polyubiquitinated proteins. As shown in Figure 3D, im- port the hypothesis that HDAC6 is required for the trans-
port of misfolded and aggregated proteins necessarymunoprecipitation of endogenous dynein brought down
a series of polyubiquitinated proteins from MG132- for aggresome formation.
To determine the functional domains of HDAC6 re-treated A549 cells, demonstrating that dynein indeed
binds polyubiquitinated proteins. To determine if HDAC6 quired for aggresome formation, we reintroduced wild-
type, catalytically inactive, or ubiquitin binding-deficientis required for this interaction, we examined the associa-
tion of dynein and polyubiquitinated proteins in A549 mutant (BUZ) HDAC6 into the knockdown cells and
assessed whether the MG132-induced aggresome for-cells stably expressing an HDAC6 siRNA that signifi-
cantly reduced levels of HDAC6 (Figure 3E). As shown in mation was restored. To prevent degradation of these
expression plasmids by the stable siRNA present inFigure 3D, the abundance of polyubiquitinated proteins
coimmunoprecipitated with dynein was dramatically re- these cells, silent mutations were introduced into the
sequences targeted by the HDAC6 siRNA. As shown induced in the HDAC6 knockdown cells (compare lanes
2 and 4). Collectively, these results are consistent with Figures 4C–4E, reintroduction of wild-type HDAC6 led
to a significant restoration of aggresome formation inthe idea that HDAC6 mediates the binding of dynein
motors to polyubiquitinated misfolded proteins. HDAC6 knockdown cells (4Ce and 4Cf) as revealed by
both an increased percentage of aggresome-containing
cells (4D) and the size of aggresomes (4E). This result
verifies a pivotal role of HDAC6 in aggresome formation.HDAC6 Is Required for Aggresome Formation
We have shown that HDAC6 is a component of aggre- In contrast to wild-type HDAC6, neither the deacetylase-
deficient (DC) nor the ubiquitin binding-deficient HDAC6somes, binds both polyubiquitinated misfolded proteins
and the dynein motor, and is required for dynein to mutant (BUZ) had significant activity in restoring aggre-
some formation (Figures 4D and 4E). Similarly, wild-type,recruit polyubiquitinated proteins. These observations
led us to hypothesize that that HDAC6 functions to load but not mutant, HDAC6 rescues CFTRF508 aggresome
formation in HDAC6 knockdown cells (data not shown).polyubiquitinated misfolded proteins onto the dynein
These results demonstrate that both deacetylase activ-motor for transport to aggresomes. Were this hypothesis
ity and ubiquitin binding activity are required for HDAC6true, HDAC6 should be required for the proper formation
to regulate aggresome formation.of the aggresome.
To test this hypothesis, we analyzed aggresome for-
mation in HDAC6 knockdown cells. We first examined HDAC6 Is Concentrated in Lewy Bodies
if CFTR-F508-induced aggresomes form normally in of Parkinson’s Disease
HDAC6 knockdown cells. As shown in Figure 4Aa, over- Lewy bodies share many characteristic features with
expression of CFTR-F508 readily induces aggresomes aggresomes and are hallmarks of several neurodegener-
of moderate size in control cells 10 hr post MG132 treat- ative disorders, including Parkinson’s disease and de-
ment. In contrast, CFTR-F508 appears to be toxic to mentia with Lewy bodies (DLB). The requirement of
HDAC6 knockdown cells in the presence of MG132 (de- HDAC6 for aggresome formation prompted us to deter-
tailed discussion in next section). In HDAC6 knockdown mine whether HDAC6 is also involved in the formation
cells that survived treatment, no CFTR-F508 aggre- of Lewy bodies. To this end, we performed immunostain-
some formation was observed (Figure 4Ab). By con- ing on brain sections from patients with Parkinson’s
disease or with dementia with Lewy bodies. In thesetrast, GFP-250 aggresomes formed normally in HDAC6
HDAC6 Regulates Aggresome Formation
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Figure 4. HDAC6 Is Required for Proper Aggresome Formation
(A) CFTR-F508 (a and b), but not GFP-250 (c and d), aggresome formation is impaired in HDAC6 knockdown cells. CFTR-F508 aggresome
formation (arrowhead) was assessed in control and HDAC6 knockdown cells as described in Figure 2A, except for a shorter MG132 treatment
(10 hr). Inset: higher magnification revealed that CFTR-F508 appeared as microaggregates (arrow) in knockdown cells. Scale bar  5 m.
(B and C) MG132-induced aggresome failed to form (B) or formed with reduced size (C) in HDAC6 knockdown cells as revealed by immunostain-
ing with an antibody against polyubiquitin (B), HDAC6, or vimentin (C) as indicated. Note that the presence of polyubiquitin microaggregates
in HDAC6 knockdown cells (Bb). Scale bar  3 m.
(D and E) Quantification of percentage of cells contain aggresomes (D) and the size of aggresomes (E) in control A549, HDAC6 knockdown
cells, and HDAC6 knockdown cells reintroduced with wild-type (wt), catalytically inactive (DC), or ubiquitin binding deletion mutant (BUZ)
HDAC6 as indicated. Error bars (D) represent standard deviation (SD) calculated from 10 random fields. The mean volume of aggresomes
that formed in control cells, knockdown cells, and knockdown cells reintroduced with various HDAC6 constructs is shown in (E). Student’s t
test was used for statistical analysis.
tissue samples, Lewy bodies are easily identifiable as and 5E). These results demonstrate that HDAC6 is also
a component of Lewy bodies associated with neurode-large inclusion bodies with a high concentration of
-synuclein and ubiquitin. As shown in Figures 5B and generative diseases.
5D, immunostaining with an antibody for HDAC6 reveals
intense staining in prominent inclusion bodies present Loss of HDAC6 Leads to Hypersensitivity
to Misfolded Protein-Induced Stressin brain sections from patients with Parkinson’s disease
and patients with dementia with Lewy bodies. Immuno- The failure to process misfolded and aggregated pro-
teins often results in cell death and is a likely a contribu-staining of the adjacent sections demonstrated that
these inclusion bodies are Lewy bodies, as they are also tor to the pathogenesis of Parkinson’s and related neu-
rodegenerative diseases. To determine whether HDAC6positive for -synuclein and ubiquitin (Figures 5A, 5C,
Cell
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Figure 5. HDAC6 Is Concentrated in the Lewy Bodies of Parkinson’s Disease and Dementia with Lewy Bodies
Series of adjacent sections of neocortical Lewy bodies in Parkinson’s disease brain (A and B, arrows) and brainstem Lewy bodies in brain
sections from patients suffering from dementia with Lewy bodies (C–E, arrows) were immunostained with antibodies for HDAC6, ubiquitin-
protein conjugates, and -synuclein as indicated.
is crucial for cell management of misfolded protein- derwent apoptosis, compared with only 10% of control
cells. In contrast, ectopic expression of GFP-250 ininduced stress, we assessed the viability of HDAC6
knockdown cells in response to accumulation of mis- HDAC6 knockdown cells did not lead to appreciable cell
death (data not shown), further establishing that thefolded proteins induced by inhibition of proteasome ac-
tivity or by ectopic expression of CFTR-F508. As requirement of HDAC6 for viability is specific for polyu-
biquitinated misfolded CFTR-F508. Importantly, theshown in Figures 6A and 6B, TUNEL assays revealed
that MG132 treatment caused a fraction (10% to15%) hypersensitivity of HDAC6 knockdown cells to CFTR-
F508 can be significantly alleviated by the reintroduc-of control A549 cells to undergo apoptosis over time.
The same treatment, however, resulted in a significantly tion of wild-type, but not catalytically inactive or ubiqui-
tin binding-deficient, HDAC6 (Figure 6C and 6D).higher percentage (20%–30%) of apoptosis in HDAC6
knockdown cells. These results indicate that loss of Together, these results demonstrate that HDAC6 is es-
sential for cell viability in response to polyubiquitinatedHDAC6 renders cells more sensitive to misfolded protein
stress induced by MG132 treatment. misfolded protein-induced stress.
We next tested whether HDAC6 is specifically re-
quired for cellular responses to accumulation of the Discussion
polyubiquitinated misfolded protein, CFTR-F508. To
that end, we transfected GFP-CFTR-F508 or GFP-250 The aggresome has emerged as a key organelle in the
clearance of toxic cytoplasmic misfolded protein aggre-into control and HDAC6 knockdown cells and analyzed
their viability. Although GFP-CFTR-F508 expresses gates often linked with cell death in neurodegenerative
diseases. Despite the potential importance of the aggre-and induces aggresome formation in control cells in the
presence of MG132 (36 hr treatment), repeated efforts some in managing stress induced by misfolded and
aggregated proteins, and its association with neurode-failed to recover viable GFP-CFTR-F508-expressing
HDAC6 knockdown cells under the same experimental generative disease, few protein factors critical for aggre-
some formation, other than the dynein motor and molec-conditions (data not shown). This result suggests that
accumulation of misfolded GFP-CFTR-F508 is ex- ular chaperones, have been identified. Additionally, we
do not know how the dynein motor machinery specifi-tremely toxic to HDAC6 knockdown cells. We subse-
quently investigated GFP-CFTR-F508 cytotoxicity in cally recognizes misfolded and aggregated proteins for
transport to aggresomes. In this study, we have identi-the absence of MG132. Under this condition, the expres-
sion of GFP-CFTR-F508 in HDAC6 knockdown cells fied HDAC6 as a factor crucial for aggresome formation,
the recruitment of misfolded protein aggregates to theagain led to profound cell death (Figures 6Cb, 6Cg, and
6Cl). Quantification shows that more than 75% of GFP- dynein motor for transport, and cell survival in response
to misfolded protein-induced stress.CFTR-F508-transfected HDAC6 knockdown cells un-
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Figure 6. Loss of HDAC6 Leads to Hypersen-
sitivity to Misfolded Protein-Induced Stress
(A) More HDAC6 knockdown cells appear to
be refractile as judged by phase contrast mi-
croscopy (a and b) and are positive for TUNEL
staining (c and d; arrowheads) in response to
MG132 treatment. Scale bar  7.5 m.
(B) The number of apoptotic cells in control
and HDAC6 knockdown cells 0–48 hr after
MG132 (5 M) treatment was counted and
graphed. Error bars represent standard devi-
ation (SD) calculated from 3 experiments.
(C) GFP-CFTR-F508 expression plasmids
were transfected into A549 control (a, f, and
k) or HDAC6 knockdown cells alone (b, g, and
l) or with wild-type (c, h, m, and p), catalytic
inactive DC (d, i, n, and q), or BUZ mutant
HDAC6 (e, j, o, and r). The GFP-CFTR-F508
expressing cells were identified by immuno-
staining with an antibody for GFP (a–e), and
nuclear morphology was visualized by Hoechst
33258 (f–j). Note that many GFP-CFTR-
F508-expressing HDAC6 knockdown cells
contain condensed and fragmented nuclei
(arrowheads in g). The condensed nuclear
morphology can be reversed by the reintro-
duction of wild-type HDAC6 (arrow in h; ar-
rowheads point to condensed nuclei in cells
expressing GFP-CFTR-F508 but not HDAC6),
but not by DC and BUZ mutant HDAC6 (ar-
rowheads in i and j). The expression of rein-
troduced FLAG-tagged wild-type and mutant
HDAC6 was identified by immunostaining
with an antibody for FLAG (m–o, red). Scale
bar  5 m.
(D) Quantification of CFTR-F508-induced
cell death described in (C) by scoring cells
with condensed and fragmented nuclei 12–36
hr after transfection. Error bars represent
standard deviation (SD) calculated from 3 ex-
periments.
HDAC6 Is a Component in Aggresomes Induced (Figure 4), and the greater apoptotic response of these
cells to the accumulation of misfolded proteins (Fig-by Misfolded Proteins
Aggresomes eliminate cytoplasmic misfolded protein ure 6).
aggregates by either functioning as proteolysis centers
specialized in degrading misfolded and aggregated pro- HDAC6: A Bridge between Ubiquitinated-
Misfolded Proteins and the Dynein Motorteins or as collection centers for their efficient degrada-
tion, possibly by an autophagosome-dependent path- The capacity to associate with both polyubiquitinated
misfolded proteins (Figure 2) and dynein motors (Figureway (reviewed in Garcia-Mata et al., 2002). Supporting
the central importance of aggresomes as a cellular re- 3) provides the framework to understand how HDAC6
regulates aggresome formation. Dynein motors are pro-sponse to cope with stress triggered by misfolded pro-
tein aggregates, aggresomes are induced by diverse posed to transport misfolded and aggregated proteins
from the cytoplasm to the MTOC and are essential foragents that cause the accumulation of misfolded pro-
teins (Figure 1). Importantly, treatment with the same the formation of aggresomes. Indeed, by video time-
lapse microscopy, small protein aggregates were foundagents invariably led to a dramatic translocation of the
deacetylase HDAC6 to aggresomes (Figure 1), establish- to be actively transported toward aggresomes (Garcia-
Mata et al., 1999). However, neither the dynein motor noring HDAC6 as a component in aggresomes. The signifi-
cance of this observation is revealed by the failure of its associated dynactin complex has a known ubiquitin
binding capacity. It has been a puzzle as to how polyubi-proper aggresome formation in HDAC6-deficient cells
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quitinated misfolded and aggregated proteins are rec-
ognized by the dynein motor for their eventual transport
to aggresomes. Our study now provides an answer to
this puzzle by placing HDAC6 as the bridge between
the polyubiquitinated misfolded cargo and the dynein
motor. Three lines of evidence support this hypothesis.
First, HDAC6 can bind both polyubiquitinated mis-
folded proteins and dynein motors. We showed that
HDAC6 binds polyubiquitinated misfolded CFTR-F508
via its C terminus ubiquitin binding BUZ domain (Figure
2), whereas it binds the dynein motor through a separate
domain (DMB, Figure 3C). Thus, HDAC6 can in theory
simultaneously associate with both polyubiquitinated
misfolded proteins and the dynein motor, facilitating
the loading of cargo to the motor (Figures 2A and 3B).
Indeed, we showed that HDAC6 is required for dynein
to bind polyubiquitinated proteins (Figure 3D) and for
the transport of misfolded proteins to aggresomes (Fig-
ures 4A–4C).
Second, HDAC6 colocalizes with both the dynein mo-
tor complex and CFTR-F508 in cytoplasmic microag-
gregates. Immunolocalization demonstrates a clear co-
localization between HDAC6 and dynein as well as
HDAC6 and CFTR-F508 in small cytoplasmic foci dur-
ing the course of aggresome formation (Figures 2 and
3). These results indicate that misfolded-CFTR-F508-
aggregates, HDAC6, and dynein form complexes prior
to transport to the juxtanuclear aggresome. By virtue of
its ability to interact with both misfolded protein cargo
and the dynein motor complex, HDAC6 can act to collect
and transport cytoplasmic misfolded protein aggregates
to the aggresome.
Figure 7. Model for HDAC6-Dependent Processing of MisfoldedThird, misfolded protein aggregates fail to concen-
Proteins and Aggresome Formationtrate into aggresomes in HDAC6-deficient cells. If
Numbers indicate various steps during aggresome biogenesis asHDAC6 facilitates the loading of misfolded protein ag-
described in the discussion.gregates to the dynein motors, one would predict that,
in the absence of HDAC6, misfolded proteins will remain
as cytoplasmic aggregates, as they cannot be trans- specific targets of HDAC6 deacetylase activity will be
ported to aggresomes. Indeed, instead of a single aggre- essential to fully understand how reversible acetylation
some, small ubiquitin-containing microaggregates are regulates aggresome formation.
found throughout the cytoplasm in a majority of HDAC6
knockdown cells treated with MG132 (Figure 4B). Impor- HDAC6 and Polyubiquitinated Misfolded Proteins
tantly, this is the exact phenotype observed when dynein The involvement of HDAC6 in aggresomes appears to
motor activity is inhibited in the presence of aggresome- be highly selective. Although HDAC6 is concentrated in
promoting agents (Garcia-Mata et al., 1999). These ob- aggresomes induced by CFTR-F508, it is not enriched
servations place HDAC6 and the dynein motor in a func- in GFP-250-containing aggresomes. Both types of ag-
tional complex essential for aggresome formation. gresomes share all the known features associated with
Notably, a catalytically inactive HDAC6 mutant failed aggresomes, except for one key difference: the CFTR-
to rescue aggresome formation and the hypersensitivity F508 aggresomes contain abundant polyubiquitin, but
to misfolded proteins in HDAC6 knockdown cells (Fig- GFP-250 aggresomes do not (Garcia-Mata et al., 1999).
ures 4 and 6). This result suggests that HDAC6 does How does HDAC6 achieve this specificity, and how im-
not function simply as an adaptor that physically links portant is this selectivity?
polyubiquitinated misfolded proteins to dynein motors, The answer to the first question may lie, in part, in the
but that a deacetylation event is also required for aggre- fact that HDAC6 contains an ubiquitin binding domain,
some formation. As the only known substrate for the BUZ finger. Although it does not bind unmodified
HDAC6, it is reasonable to speculate that the deacetyla- CFTR-F508 with appreciable affinity, HDAC6 specifi-
tion of microtubules by dynein-associated HDAC6 might cally binds polyubiquitinated misfolded CFTR-F508 via
somehow facilitate the transport of dynein-misfolded the BUZ finger (Figure 2). The selective presence of
protein complexes along microtubules to the MTOC. HDAC6 in CFTR-F508-induced aggresomes might be
It is, however, equally possible that deacetylation of explained by its specific binding of polyubiquitinated
substrates other than -tubulin might be critical for misfolded CFTR-F508 (Figure 2). Since misfolded GFP-
250 is not polyubiquitinated, HDAC6 does not recognizeHDAC6 to manage the misfolded proteins. Identifying
HDAC6 Regulates Aggresome Formation
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it (Figure 2B). Consequently, HDAC6 is not present in cape degradation due to abnormal or pathological con-
ditions and form toxic aggregates (3). These misfoldedGFP-250 aggresomes (Figure 2A). Further supporting
this idea of selectivity, HDAC6 is specifically required and aggregated proteins are recognized and bound by
HDAC6 through the presence of polyubiquitin chainsfor aggresomes induced by CFTR-F508 but dispens-
able for those induced by GFP-250 (Figure 4A). The (4). This allows for the loading of polyubiquitinated mis-
folded protein cargo onto the dynein motor complex byimportance of this specificity can be easily appreciated
by the failure to concentrate misfolded CFTR-F508 to HDAC6 (5). The polyubiquitinated cargo-HDAC6-dynein
motor complex then travels to the aggresome, whereaggresomes in HDAC6 knockdown cells (Figure 4A),
leading to massive apoptosis (Figure 6). In stark con- the misfolded and aggregated proteins are processed
and degraded (6), clearing the cell of cytotoxic proteintrast, no cytotoxicity is associated with GFP-250 expres-
sion in the same HDAC6-deficient cells. Thus, HDAC6 aggregates. Our results establish the deacetylase
HDAC6 as a critical component in managing misfoldedappears to be the specific adaptor enabling dynein mo-
tors to recognize and associate with the polyubiquiti- protein-induced stress, further expanding the functional
repertoire for HDAC family members and reversiblenated misfolded cargo. This conclusion would also pre-
dict the existence of specific adaptor(s) for loading the acetylation beyond histone metabolism and gene tran-
scription.nonubiquitinated misfolded protein cargo, which are
also likely associated with neurodegenerative diseases
(Johnston et al., 2000). Experimental Procedures
Cell Lines and TransfectionHDAC6, Aggresomes, Lewy Bodies, and Misfolded
All cells were maintained in Dulbecco’s Modified Eagle’s Medium
Protein-Induced Cell Death (DMEM) with 10% fetal bovine. Transfections were performed with
The appearance of intracellular inclusion bodies con- FuGENE6 (Roche) or by the calcium phosphate method. A retrovirus-
taining misfolded proteins has emerged as a common mediated pSUPER RNAi system (OligoEngine) was used to establish
the A549 line expressing an RNAi for HDAC6. Silent mutationstheme in many neurodegenerative diseases, including
(G237C, G240A, and A243C) were introduced into wild-type andParkinson’s disease, Huntington’s disease, and related
mutant HDAC6 that were reintroduced into the knockdown cells.neurodegeneration caused by expanded polyglutamine
(PolyQ) tract in specific disease genes (Tran and Miller,
Antibodies and Plasmids1999). It is generally believed that the inability to process
The anti ()-HDAC6 antibody has been described previously (Hub-misfolded and aggregated proteins causes the forma-
bert et al., 2002). The following antibodies were used in this study:
tion of these inclusion bodies. Whether inclusion bodies -vimentin (V9, H-84 Santa Cruz), --tubulin (GTU-88, Sigma),
are cytotoxic or cytoprotective in the process of neuro- -20S-proteasome (HC8), -ubiquitin-protein conjugates (Affiniti
Research Products), -dynein (70.1, Sigma), -ubiquitin (clonedegeneration, however, is still under debate. In this re-
P467), -FLAG (M2, Sigma), -GFP (clone 7.1 and 13.1, Roche),gard, aggresomes are of particular interest as they might
--synuclein (BD Transduction Laboratories), and -myc (9E10,serve as a model for studying cytoplasmic inclusion
Sigma). pCDNA3-FLAG-tagged wild-type and mutant HDAC6 werebodies like Lewy bodies. Our observation that HDAC6
generated as described elsewhere (J.J. Kovacs and T.-P. Yao, sub-
is highly enriched in both aggresomes and Lewy bodies mitted).
further establishes the similarity between these two in-
clusion bodies. In this study, we demonstrate that Immunostaining
HDAC6 deficiency results in defects in aggresome for- Immunofluorescence was performed as described previously (Hub-
mation accompanied by massive cell death in response bert et al., 2002) except for experiments visualizing the 20S-protea-
some and ubiquitin-protein conjugates, in which cells were fixed into misfolded protein-induced stress (Figure 6). Interest-
methanol at 20C. For immunostaining of Lewy bodies, all tissueingly, inhibition of aggresome formation by disruption of
from patients that had confirmed postmortem diagnoses of Parkin-the microtubule network also increases the cytotoxicity
son’s disease (PD) and dementia with Lewy bodies (DLB) was fixed
associated with misfolded proteins (Taylor et al., 2003). in 10% formalin, paraffin embedded, and serially sectioned at 8 m
These observations support the idea that aggresome thickness. Adjacent slides were stained for -HDAC6, -synuclein,
formation is part of a cytoprotective response. HDAC6 and -ubiquitin-protein conjugates. Vector ABC kit (Vector labora-
tories) was used to visualize the stain and counterstained with hema-could protect cells by facilitating the removal of harmful
toxylin.misfolded protein aggregates from the cytoplasm and
concentrating them into aggresomes for efficient pro-
Quantification of Aggresome-Containing Cellscessing and degradation. Thus, the formation of dis-
and Measurement of Aggresome Sizeease-associated cytoplasmic inclusion bodies, such as
For quantification, ten fields of each sample were randomly se-
Lewy bodies, is likely a cytoprotective response of af- lected. The percentage of cells containing aggresomes was
fected neurons to combat misfolded protein-induced counted. For measurement of the volume of aggresome, 75 cells of
stress. The presence of HDAC6 in Lewy bodies suggests each sample were randomly selected. The volume of aggresomes
was measured using confocal microscopy software (UltraView, Per-that HDAC6 is also an important factor for neuronal
kin Elmer). Student’s t test was used for statistical comparison.survival during the process of neurodegeneration. The
delineation of the role for HDAC6 in regulating misfolded
Cell Death Assayprotein response could have important implications for
Apoptotic cells induced by MG132 were detected by the TUNELthe treatment of neurodegenerative disease.
method using the In Situ Cell Death Detection Kit (Roche). ThreeBased on our results, we propose the model depicted
hundred cells were analyzed. For CFTR-F508-induced cell death,
in Figure 7, which shows that misfolded proteins be- cell nuclei were visualized by staining with Hoechst 33258 (Sigma).
come polyubiquitinated (1) and normally degraded by One hundred CFTR-F508-expressing cells were analyzed for the
presence of condensed or fragmented nuclei.proteasomes (2). However, misfolded proteins can es-
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